Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study

H Lee Moffitt Cancer Center, Tampa, FL, USA. anna.giuliano@moffi
The Lancet (Impact Factor: 45.22). 02/2011; 377(9769):932-40. DOI: 10.1016/S0140-6736(10)62342-2
Source: PubMed


Human papillomaviruses (HPVs) cause genital warts and cancers in men. The natural history of HPV infection in men is largely unknown, and that information is needed to inform prevention strategies. The goal in this study was to estimate incidence and clearance of type-specific genital HPV infection in men, and to assess the associated factors.
Men (aged 18-70 years), residing in Brazil, Mexico, and the USA, who were HIV negative and reported no history of cancer were recruited from the general population, universities, and organised health-care systems. They were assessed every 6 months for a median follow-up of 27·5 months (18·0-31·2). Specimens from the coronal sulcus, glans penis, shaft, and scrotum were obtained for the assessment of the status of HPV genotypes.
In 1159 men, the incidence of a new genital HPV infection was 38·4 per 1000 person months (95% CI 34·3-43·0). Oncogenic HPV infection was significantly associated with having a high number of lifetime female sexual partners (hazard ratio 2·40, 1·38-4·18, for at least 50 partners vs not more than one partner), and number of male anal-sexual partners (2·57, 1·46-4·49, for at least three male partners vs no recent partners). Median duration of HPV infection was 7·52 months (6·80-8·61) for any HPV and 12·19 months (7·16-18·17) for HPV 16. Clearance of oncogenic HPV infection decreased in men with a high number of lifetime female partners (0·49, 0·31-0·76, for at least 50 female partners vs not more than one partner), and in men in Brazil (0·71, 0·56-0·91) and Mexico (0·73, 0·57-0·94) compared with the USA. Clearance of oncogenic HPV was more rapid with increasing age (1·02, 1·01-1·03).
The data from this study are useful for the development of realistic cost-effectiveness models for male HPV vaccination internationally.
National Cancer Institute.

Download full-text


Available from: Anna R Giuliano,
  • Source
    • "A high prevalence of HPV (44.8%) is found in U.S. women 20 to 24 years old (30% low and 28% high-risk subtypes), compared with 24.5% for U.S. women over the broader age range of 14 to 49 (Dunne et al., 2007). Risk might be even greater for men: 50% prevalence was reported among men 18 to 70 years old (38% low risk and 30% high risk subtypes; Giuliano et al., 2011). There is no treatment for the virus, and although most precancerous cells normalize on their own, some do not and can cause anogenital warts and cervical, vulvar, vaginal, penile, anal, or oropharangeal cancer (CDC, 2013b), as well as psychological and sexual consequences (e.g., anger, anxiety, stigma, lower sexual desire) for the individual and relationship partner(s) (Chaturvedi, 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The odds of developing cancer are increased by specific lifestyle behaviors (tobacco use, excess energy and alcohol intakes, low fruit and vegetable intake, physical inactivity, risky sexual behaviors, and inadequate sun protection) that are established risk factors for developing cancer. These behaviors are largely absent in childhood, emerge and tend to cluster over the life span, and show an increased prevalence among those disadvantaged by low education, low income, or minority status. Even though these risk behaviors are modifiable, few are diminishing in the population over time. We review the prevalence and population distribution of these behaviors and apply an ecological model to describe effective or promising healthy lifestyle interventions targeted to the individual, the sociocultural context, or environmental and policy influences. We suggest that implementing multiple health behavior change interventions across these levels could substantially reduce the prevalence of cancer and the burden it places on the public and the health care system. We note important still-unresolved questions about which behaviors can be intervened upon simultaneously in order to maximize positive behavioral synergies, minimize negative ones, and effectively engage underserved populations. We conclude that interprofessional collaboration is needed to appropriately determine and convey the value of primary prevention of cancer and other chronic diseases. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
    American Psychologist 02/2015; 70(2):75-90. DOI:10.1037/a0038806 · 6.87 Impact Factor
  • Source
    • "The mean duration of infertility in couples of participants in our study was almost two years, supposing that the duration of their stable sexual relationships was even longer. Taking into account the clearance time of HPV infection, which is generally shorter than two years in men, we expected much lower HPV prevalence [42]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human papillomaviruses (HPV) are the most frequently sexually transmitted viruses and etiological agents of several human cancers. Controversial results of the role of HPV in infertile population on sperm parameters have been published. The aim of this study was to estimate the type-specific prevalence of HPV DNA infection of the external genitalia and semen in 340 Slovenian men from infertile couples and to establish the relationship between seminal HPV DNA infection and abnormal sperm parameters. Self-taken swabs of the entire penile surface and semen samples were collected, and HPV detection and genotyping were performed. HPV DNA was detected in 37.12% of external genitalia and in 13.61% of semen samples with high HPV type concordance of both sampling sites. The most prevalent HPV types in the male external genitalia were HPV-CP6108 and HPV-84. The most prevalent HPV types in semen were HPV-53 and HPV-CP6108. The prevalence of HPV infection between normozoospermic men and men with abnormal sperm parameters did not differ significantly. Sperm quality did not differ significantly between men with seminal HPV infection and uninfected men. In conclusion, the men from infertile couples are equally susceptible to HPV infection regardless of their fertile potential; seminal HPV infection does not impair sperm quality.
    04/2014; 2014(9):956901. DOI:10.1155/2014/956901
  • Source
    • "The most important clinical consequence of HPV infection is cervical cancer which remains one of the leading causes of cancer-related mortality in young and older women [2] [3] [4] [5]. HPV infection is also related to anogenital warts and different neoplasia, such as vaginal, vulvar, penile, anal, oral cavity, head, and neck cancers [1] [4] [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent evidences identify Human Papillomavirus (HPV) sperm infection as a possible cause of male and couple infertility. It acts through different mechanisms at various steps of human conception and early gestational development. We performed a systematic review to assess the role of HPV semen infection on male and couple infertility. Analysis of available and eligible data does not permit us to fund clear evidences about clinical impact of HPV infection on fertility, although sperm parameters impairment is the most widely recognized effect. Regarding biomolecular implications, the available data are often conflicting. More studies are required to define the role of HPV sperm infection in clinical practice. The great majority of evidences are obtained by in vitro studies and this fact represents a limitation for the clinical management of HPVDNA sperm infection. Understanding the biological significance of HPV-DNA semen infection could permit us to explain most of the idiopathic male and couple infertility, leading to a better management of infertile men and a better timing for sperm banking storage before ART cycles.
    03/2014; 2014:230263. DOI:10.1155/2014/230263
Show more